TSX/LOVE (TSX/LOVE)

Toronto Stock Exchange: TSX/LOVE · CAD

CA$1.97

-0.05 (-2.5%)· Recorded snapshot

Market cap	194.5M
Revenue (ttm)	117.3M
Net income (ttm)	10.9M
EPS (ttm)	CA$0.11
Shares out	98.7M
P/E (trailing)	17.9x
P/E (forward)	11.1x
Volume	74,672
Beta	0.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 117.3M
Net income (ttm): 10.9M
EPS (ttm): CA$0.11
P/E (trailing): 17.9x
P/E (forward): 11.1x
Market cap: 194.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E17.9

P25 n/aP50 n/aP75 n/a

ROE9.7

P25 n/aP50 n/aP75 n/a

ROIC8.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/LOVE indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

CAD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-24
Employees	452
Employees change	89
Employees growth	24.52%
Enterprise value	CAD 209.7M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-05-31
First seen	2026-05-10
Fiscal year end	August
Founded	2017
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA13765U2002
Last earnings date	2026-07-15
Last refreshed	2026-10-29
Last stock split date	2023-02-13
Last stock split type	Reverse
Market cap	CAD 194.5M
Next earnings date	2026-11-24
Price	CAD 1.97
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsx/LOVE
Website	https://cannara.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	12.01x
Average P/E ratio (5Y)	29.33x
Earnings yield	5.58%
EV/Earnings	19.76x
EV/EBIT	11.76x
EV/EBITDA	8.58x
EV/FCF	37.69x
EV/Sales	1.83x
FCF / EV yield	2.65%
FCF yield	2.86%
Forward P/E	11.07x
Graham number	1.77522
Graham upside	-12.12%
Industry forward P/E	34.38x
Lynch fair value	CAD 2.75
Lynch upside	36.07%
P/(FCF - SBC) ratio	112.37x
P/(OCF - SBC) ratio	12.87x
P/B ratio	1.58x
P/E ratio	17.92x
P/FCF ratio	35.02x
P/OCF ratio	10.27x
P/S ratio	1.7x
Price / tangible book value	1.62x
Price/EBITDA ratio	8.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.55%
EBITDA margin	21.08%
Effective tax rate	33.28%
FCF margin	4.85%
Gross margin	42.59%
Operating margin	15.55%
Pretax margin	13.87%
Profit margin	9.25%
Profit per employee	CAD 24,023
Profitable quarters	9
Profitable years	4
Revenue per employee	CAD 259,588
ROA	6.26%
ROA (5Y)	3.98%
ROCE	11.27%
ROE	9.68%
ROE (5Y)	6.29%
ROIC	8.9%
ROIC (5Y)	6.81%
SBC / revenue	3.34%
Tax / revenue	4.62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-35.26%
EPS growth (Q)	22.56%
EPS growth (QoQ)	184.13%
EPS growth 3Y	26.03%
EPS growth quarters	1
EPS growth years	1
FCF growth	-62.01%
FCF growth (Q)	-89.08%
Gross profit growth	9.55%
Gross profit growth (Q)	16.68%
Gross profit growth 3Y	26.59%
Gross profit growth 5Y	55.17%
Net income growth	-30.02%
Net income growth (Q)	16.91%
Net income growth (QoQ)	191.26%
Net income growth 3Y	30.67%
Net income growth quarters	1
Net income growth years	1
OCF growth	-4.69%
OCF growth (Q)	-59.13%
OCF growth (QoQ)	92.71%
Operating income growth	-15.78%
Operating income growth (Q)	8.79%
Operating income growth 3Y	23.3%
Revenue growth	14.84%
Revenue growth (Q)	16.45%
Revenue growth (QoQ)	17.1%
Revenue growth 3Y	31.95%
Revenue growth 5Y	59.49%
Revenue growth quarters	27
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -13.7M
Depreciation and amortization	CAD 6.5M
EBIT	CAD 18.2M
EBITDA	CAD 24.7M
EPS	CAD 0.11
FCF per share	CAD 0.06
Financing cash flow	CAD 3.8M
Free cash flow	CAD 5.7M
Free cash flow minus SBC	CAD 1.8M
Gross profit	CAD 50M
Income taxes	CAD 5.4M
Investing cash flow	CAD -15.8M
Net borrowing	CAD -98,083
Net cash flow	CAD 7.4M
Net income	CAD 10.9M
Operating cash flow minus SBC	CAD 15.5M
Operating income	CAD 18.2M
Revenue	CAD 117.3M
Stock-based compensation	CAD 3.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.81
Book value per share	CAD 1.27
Debt / EBITDA	1.48
Debt / equity	0.29
Debt / FCF	6.5
Interest coverage	7.69
Long-term assets	CAD 96.8M
Long-term liabilities	CAD 36.1M
Net cash (debt)	CAD -15.2M
Net cash / market cap	-7.62%
Net debt / EBITDA	0.61
Net debt / equity	0.12
Net debt / FCF	2.67
Piotroski F-Score	7
Property, plant and equipment	CAD 93M
Shareholders' equity	CAD 125.8M
Tangible book value	CAD 123.2M
Tangible book value per share	CAD 1.25
Total assets	CAD 194.5M
Total cash	CAD 21.8M
Total debt	CAD 37M
Total liabilities	CAD 68.6M
WACC	5.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current assets	CAD 97.7M
Current liabilities	CAD 32.6M
Current ratio	3
Inventory turnover	1.29
Net working capital	CAD 53.1M
Quick ratio	1.24
Working capital	CAD 65.1M
Working capital turnover	2.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.67%
Shareholder yield	-5.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 1.88
1D price change	-2.48%
1M price change	-7.87%
1M total return	-7.87%
1W price change	-1.49%
1W total return	-1.49%
1Y price change	17.06%
1Y return CAGR	17.07%
1Y total return	17.06%
20-day SMA	CAD 2.07
200-day SMA	CAD 1.87
3M price change	5.29%
3M total return	5.29%
3Y price change	105.16%
3Y return CAGR	27.06%
3Y total return	105.16%
50-day SMA	CAD 2.04
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 2.37
52-week high date	2026-09-25
52-week low	CAD 1.55
52-week low date	2026-06-24
5Y price change	42.14%
5Y return CAGR	7.29%
5Y total return	42.14%
6M price change	12.43%
6M total return	12.43%
All-time high	CAD 3.45
All-time high date	2019-01-14
All-time low	CAD 0.50
All-time low date	2019-07-08
Average true range (ATR)	CAD 0.06
Average volume	33.1K
Beta (1Y)	0.47
Beta (2Y)	0.48
Beta (5Y)	0.27
Change from 52-week high	-16.88%
Change from 52-week low	27.1%
Change from all-time high	-42.32%
Change from all-time low	298%
Change from open	-1.99%
Day's gap	-0.5%
Dollar volume	CAD 147,104
High price	CAD 2.01
Low price	CAD 1.97
Monthly RSI	64.39
Open price	CAD 2.01
Position in 52-week range	0%
Previous close	CAD 2.02
Price vs 150-day SMA	6.13%
Price vs 20-day SMA	-3.63%
Price vs 200-day SMA	6.65%
Price vs 50-day SMA	-2.64%
Relative volume	2.25
RSI	43.3
Sharpe ratio	0.51
Sharpe ratio (3Y)	0.64
Sharpe ratio (5Y)	0.31
Sortino ratio	0.94
Sortino ratio (3Y)	1.12
Sortino ratio (5Y)	0.59
Volume	74.7K
Weekly RSI	54.04
YTD price change	14.37%
YTD total return	14.37%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45.2M
Shares change (QoQ)	2.13%
Shares change (YoY)	5.67%
Shares held by insiders	4.13%
Shares held by institutions	0.25%
Shares outstanding	98.7M

Deeper analysis on TSX/LOVE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/LOVE report

Is a complete TSX/LOVE research report available?

No complete published report is available for tsx/LOVE (TSX/LOVE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/LOVE (TSX/LOVE)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/LOVE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/LOVE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/LOVE

Frequently asked questions